EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update

Maud Maillard iD, Matthias Schwab iD, Michelle Whirl-Carrillo iD, Ann M Moyer iD, Guilherme Suarez-Kurtz iD, Ching-Hon Pui, C Michael Stein, Teri E Klein iD, Claire Spahn iD, Sooyeon Kwon, Juanda Leo Hartono, Nanne K de Boer und 7 weitere

Clinical Pharmacology & Therapeutics · 2026-04 · 119 (4) · 916-927

DOI: 10.1002/cpt.70209 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 31.01.2026. Verfasst von Maud Maillard und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Pyrophosphatases, Methyltransferases, Mercaptopurine, Thioguanine. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thiopurine methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) are key enzymes that catabolize thiopurines. Decreased or no‐function alleles in TPMT and NUDT15 are associated with reduced or no enzyme activity and predictive of pronounced adverse effects, including severe myelosuppression, that may occur among individuals treated with standard doses of thiopurines. Genetic variants in these genes are present in all world populations; however, their frequency varies by ancestry. In this updated guideline, we provide recommendations for adjusting starting doses of mercaptopurine, thioguanine, and azathioprine based on TPMT and NUDT15 genotypes, including for individuals with variants in both genes (updates on www.clinpgx.org ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrophosphatasesMethyltransferasesMercaptopurineThioguanineAzathioprinePharmacogeneticsHumansNudix HydrolasesGenotype

Substanzen

Nudix HydrolasesPyrophosphatasesNUDT15 protein, humanMethyltransferasesMercaptopurineTPMT protein, humanThioguanineAzathioprinethiopurine methyltransferase

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Univ Toulouse, Oncopole Claudius Regaud, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.
  • Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, University Hospital, Tuebingen, Germany.
  • Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Mayo Clinic, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Maud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, Ann M Moyer, Guilherme Suarez-Kurtz, Teri E Klein, Claire Spahn, Kelly E Caudle, Motohiro Kato

Zitieren

APA

Maillard, M., Schwab, M., Whirl-Carrillo, M., Moyer, A. M., Suarez-Kurtz, G., Pui, C. H., Stein, C. M., Klein, T. E., Spahn, C., Kwon, S., Hartono, J. L., de Boer, N. K., Ahmad, T., Antillon-Klussmann, F. G., Caudle, K. E., Kato, M., Yeoh, A. E. J., Schmiegelow, K., & Yang, J. J. (2026). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. Clinical Pharmacology & Therapeutics, 119(4), 916-927. https://doi.org/10.1002/cpt.70209

Vancouver

Maillard M, Schwab M, Whirl-Carrillo M, Moyer AM, Suarez-Kurtz G, Pui CH, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. Clinical Pharmacology & Therapeutics. 2026;119(4):916-927. doi:10.1002/cpt.70209

BibTeX
@article{Maillard2026,
  author = {Maillard, Maud and Schwab, Matthias and Whirl-Carrillo, Michelle and Moyer, Ann M and Suarez-Kurtz, Guilherme and Pui, Ching-Hon and Stein, C Michael and Klein, Teri E and Spahn, Claire and Kwon, Sooyeon and Hartono, Juanda Leo and de Boer, Nanne K and Ahmad, Tariq and Antillon-Klussmann, Federico Guillermo and Caudle, Kelly E and Kato, Motohiro and Yeoh, Allen E J and Schmiegelow, Kjeld and Yang, Jun J},
  title = {Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {119},
  number = {4},
  pages = {916--927},
  doi = {10.1002/cpt.70209}
}
Kostenlos starten →